Ilhan, O. Et Al. 1997. Hematological and cytogenetic efficiency of interferon alpha 2a plus low dose cytarabine in chronic myelogenous leukemia: An interim analysis of multicenter study.. BLOOD , vol.90, no.10 , 3999.

Ilhan, O., Ozcan, M., Yalcin, A., Koc, H., BEKSAÇ, M., Unal, A., ... Tunali, A.(1997). Hematological and cytogenetic efficiency of interferon alpha 2a plus low dose cytarabine in chronic myelogenous leukemia: An interim analysis of multicenter study.. BLOOD , vol.90, no.10, 3999.

Ilhan, O Et Al. "Hematological and cytogenetic efficiency of interferon alpha 2a plus low dose cytarabine in chronic myelogenous leukemia: An interim analysis of multicenter study.," BLOOD , vol.90, no.10, 3999, 1997

Ilhan, O Et Al. "Hematological and cytogenetic efficiency of interferon alpha 2a plus low dose cytarabine in chronic myelogenous leukemia: An interim analysis of multicenter study.." BLOOD , vol.90, no.10, pp.3999, 1997

Ilhan, O. Et Al. (1997) . "Hematological and cytogenetic efficiency of interferon alpha 2a plus low dose cytarabine in chronic myelogenous leukemia: An interim analysis of multicenter study.." BLOOD , vol.90, no.10, p.3999.

@article{article, author={O Ilhan Et Al. }, title={Hematological and cytogenetic efficiency of interferon alpha 2a plus low dose cytarabine in chronic myelogenous leukemia: An interim analysis of multicenter study.}, journal={BLOOD}, year=1997, pages={3999} }